<DOC>
	<DOCNO>NCT01555190</DOCNO>
	<brief_summary>Previous study demonstrate Myo-inositol capable restore spontaneous ovarian activity , consequently fertility , patient PCOS . The aim study investigate role folic acid conteined inositol preparation . The study group include 50 patient , randomly allocate subgroup A ( myo-inositol 1500 gr ) subgroup B ( myo-inositol 2000 gr + folic acid 200 mcg ) . The investigation include menstrual pattern hirsutism score evaluation , hormonal assay , oral glucose tolerance test , euglycemic hyperinsulinaemic clamp lipide profile baseline six month treatment .</brief_summary>
	<brief_title>Combination Therapy With Myo-inositol Folic Acid Versus Myo-inositol Alone</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hirsutism</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>woman PCOS diagnose accordance Rotterdam Consensus Conference Criteria 2003 BMI &gt; 25 kg/m2 age 1835 year pregnancy significant liver renal impairment hormonal dysfunction ( hypothalamic , pituitary , thyroidal adrenal cause clinical sign ) neoplasms unstable mental illness diagnosis diabetes mellitus impaired glucose tolerance use drug able interfere glucoinsulinaemic metabolism least three month prior enter study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>myo-inositol</keyword>
	<keyword>folic acid</keyword>
</DOC>